Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany
Karl-Christian Bergmann,1 Dirk Skowasch,2 Hartmut Timmermann,3 Robert Lindner,4 Johann Christian Virchow,5 Olaf Schmidt,6 Dirk Koschel,7 Claus Neurohr,8 Sebastian Heck,9 Katrin Milger10 1Institute for Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany; 2Department of Internal Medicine II – Pneumology, University Hospital Bonn, Bonn, Germany; 3Schwerpunktpraxis Colonnaden, Hamburg, Germany; 4IQVIA Commercial GmbH & Co. OHG, Frankfurt Am Main, Germany; 5Universitätsme... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2022 |
| Reihe/Periodikum: | Journal of Asthma and Allergy, Vol Volume 15, Pp 897-906 (2022) |
| Verlag/Hrsg.: |
Dove Medical Press
|
| Schlagwörter: | prescription database / disease analyzer / uncontrolled asthma / oral corticosteroid (ocs) / short-acting β2-agonist (saba) / Immunologic diseases. Allergy / RC581-607 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26894845 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://doaj.org/article/5525bb9757f64559b88b99a6db0e270f |
